Plant cytochrome P450-mediated herbicide metabolism

被引:186
|
作者
Siminszky B. [1 ]
机构
[1] Department of Plant and Soil Sciences, University of Kentucky, Lexington
关键词
Applications; Bioremediation; Genetic engineering; Herbicide metabolism; In vitro assays; Inhibitors; Microsomes; Phase I metabolism; Safeners;
D O I
10.1007/s11101-006-9011-7
中图分类号
学科分类号
摘要
In the last two decades it has become apparent that enzymes of the P450 monooxygenase (P450) superfamily are responsible for the Phase I metabolism of numerous herbicides representing several classes of organic compounds. The majority of experimental evidence for P450 involvement in herbicide metabolism has been derived from in vitro studies in which the catalytic activity of plant microsomes towards herbicidal substrates was measured in the presence of various P450 inhibitors and activators. While the studies with microsomes elicited much appreciation for the pivotal roles of plant P450s in herbicide metabolism, detailed characterization of these enzymes only became possible after the isolation of genes encoding specific isoforms responsible for herbicide conversion. Several lines of evidence suggest that the development of herbicide resistance in weeds by enhanced detoxification is frequently associated with elevated levels of P450 activity. Enhanced detoxification-based herbicide resistance is particularly difficult to control, because it can involve resistance to multiple, chemically unrelated classes of herbicides. Continued research efforts are aimed at elucidating the role of P450s in the metabolic fates of herbicides in plants and the development of herbicide resistance in weeds. Recent advances made in the isolation and genetic manipulation of P450 enzymes have created new opportunities for their application in engineering herbicide tolerance and bioremediation. © 2006 Springer Science+Business Media B.V.
引用
收藏
页码:445 / 458
页数:13
相关论文
共 50 条
  • [31] Cytochrome P450-mediated drug interactions
    Flockhart, DA
    Oesterheld, JR
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (01) : 43 - +
  • [32] Cytochrome P450-mediated 17β-estradiol metabolism in zebrafish (Danio rerio)
    Scornaienchi, Marcus L.
    Thornton, Cammi
    Willett, Kristine L.
    Wilson, Joanna Y.
    JOURNAL OF ENDOCRINOLOGY, 2010, 206 (03) : 317 - 325
  • [33] Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women
    Shedlofsky, SI
    Israel, BC
    Tosheva, R
    Blouin, RA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) : 627 - 632
  • [34] Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites
    Avent, Kathryn M.
    DeVoss, J. J.
    Gillam, Elizabeth M. J.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (07) : 914 - 920
  • [35] Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine
    Martignoni, M
    Groothuis, G
    de Kanter, R
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (06) : 1047 - 1054
  • [36] Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats
    Nishiya, Takayoshi
    Kato, Michiyuki
    Suzuki, Takami
    Maru, Chikako
    Kataoka, Hiroko
    Hattori, Chiharu
    Mori, Kazuhiko
    Jindo, Toshimasa
    Tanaka, Yorihisa
    Manabe, Sunao
    TOXICOLOGY LETTERS, 2008, 183 (1-3) : 81 - 89
  • [37] Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds
    Waller, CL
    Evans, MV
    McKinney, JD
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (02) : 203 - 210
  • [38] Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans
    Jürgens, G
    Christensen, HR
    Brosen, K
    Sonne, J
    Loft, S
    Olsen, NV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (04) : 214 - 220
  • [39] SUBANESTHETIC CONCENTRATIONS OF DRUGS INHIBIT CYTOCHROME P450-MEDIATED METABOLISM OF ANILINE
    LABELLA, FS
    QUEEN, G
    EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION, 1995, 293 (03): : 231 - 235
  • [40] Cytochrome P450-mediated cardiovascular drug interactions
    Scheen, Andre J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (09) : 1065 - 1082